Article
Exploring the mechanism of non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitor.
Journal of cancer research and therapeutics - 1 Jan 2000
Yu Yongkang, Luo Yaohui, Zheng Yifeng, Zheng Xiushan, Li Wei, Yang Lie, Jiang Jianqing
Abstract excerpt
PURPOSE: Here we aimed to explore the possible mechanism and potential regulatory relationships in which the non.small.cell lung cancer. (NSCLC)-resisted epidermal growth factor receptor. (EGFR) tyrosine kinase inhibitor erlotinib. MATERIALS AND METHODS: GSE38310, the gene expression profiles of NSCLC cell lines treated with dimethylsulfoxide or erlotinib, including HCC827, ER3, and T15-2, were downloaded from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
